Institute of Inflammation and Ageing World leading discovery and translational science in inflammation and ageing
News Latest research finds hypertension drug could be repurposed to delay ageing Latest research has found that rilmenidine, a drug used to treat hypertension, can be used to slow ageing and extend lifespan.
News Inflammation and Ageing Research Fellow receives £1.2M Competitive MRC Career Development Fellowship
News Latest study uncovers findings of periodontal therapy in reducing rheumatoid arthritis disease activity
09 March 2021 Research aims to find new treatment for secondary brain damage New research has been launched to look at the possible re-purposing of selective P2X7 receptor blocker drugs to treat patients with secondary brain damage.
11 February 2021 Funding boost to research multi-morbidity in hospital patients Scientists have been given almost £4m to improve understanding of multi-morbidity in hospital patients.
05 February 2021 Severely frail individuals with COVID-19 are three times more likely to die, study finds New research led by the University of Birmingham has revealed for the first time the extent to which frailty increases the risk of mortality in COVID-19 patients.
15 January 2021 Government is missing its key healthy ageing targets and must act now, report finds The COVID-19 pandemic has highlighted stark inequalities in healthy life expectancy, according to a report into ageing published on Friday 15 January.
11 December 2020 University awarded over £1.5 million for new MB-PhD programme The University has been awarded funding for a new MB-PhD programme to support three intercalating students a year for five years in areas of research relevant to musculoskeletal and other inflammatory diseases.
25 November 2020 New breakthrough in the treatment of rheumatoid arthritis People with rheumatoid arthritis could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores.